Denali Therapeutics
DNLI
DNLI
209 hedge funds and large institutions have $2.49B invested in Denali Therapeutics in 2023 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 72 increasing their positions, 68 reducing their positions, and 20 closing their positions.
Holders
209
Holders Change
+15
Holders Change %
+7.73%
% of All Funds
3.06%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
37
Increased
72
Reduced
68
Closed
20
Calls
$1.82M
Puts
$1.48M
Net Calls
+$340K
Net Calls Change
-$1.02M
Top Buyers
| 1 |
1
Marshall Wace
London,
United Kingdom
|
$35.8M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$118M |
| 3 |
3
Morgan Stanley
New York
|
$42M |
| 4 |
4
BlackRock
New York
|
$248M |
| 5 |
5
Point72 Asset Management
Stamford,
Connecticut
|
$13.8M |
